These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 6257445
1. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients]. Petronio G, Scali G, Casa B, Nonis E. Clin Ter; 1980 Aug 31; 94(4):427-44. PubMed ID: 6257445 [No Abstract] [Full Text] [Related]
2. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography]. Ardito R. Clin Ter; 1979 Mar 15; 88(5):461-12. PubMed ID: 466968 [No Abstract] [Full Text] [Related]
5. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients]. Mazzola C, Della Torre F, Izzo M, Colombo Pirola L. Clin Ter; 1979 Dec 15; 91(5):485-503. PubMed ID: 397034 [No Abstract] [Full Text] [Related]
6. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil]. Caimi G, Catania A, Frazzetta F, Capobianco D, Francavilla G, Romano A, Sarno A. Ric Clin Lab; 1983 Dec 15; 13 Suppl 3():465-8. PubMed ID: 6324326 [Abstract] [Full Text] [Related]
7. [Therapy of chronic cerebrovascular arteriosclerotic insufficiency in a geriatric patient]. Cucinotta D, Palummeri E, Carapezzi C, Cocchi C. G Clin Med; 1979 Mar 15; 60(3):225-33. PubMed ID: 520728 [No Abstract] [Full Text] [Related]
8. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)]. Mikus P. Arzneimittelforschung; 1978 Mar 15; 28(11):2165-8. PubMed ID: 582924 [Abstract] [Full Text] [Related]
9. [Effects of vincamine treatment on cerebral arteriosclerotic vasculopathy]. Saba GC, Locci P, Sgromo V, Gaspa F. G Clin Med; 1976 Mar 15; 56(2):149-55. PubMed ID: 964523 [No Abstract] [Full Text] [Related]
10. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration. Baro F, Malfroid M, Waegemans T, Cox JP. Pharmatherapeutica; 1985 Mar 15; 4(6):399-404. PubMed ID: 3001778 [Abstract] [Full Text] [Related]
15. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency]. Periti P, Periti G, Colombo Pirola L. Clin Ter; 1981 Apr 30; 97(2):137-45. PubMed ID: 7016415 [No Abstract] [Full Text] [Related]
16. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects]. Schenker H. Med Klin; 1979 Oct 24; Suppl():48-50. PubMed ID: 542168 [No Abstract] [Full Text] [Related]
17. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke. Dekoninck WJ, Jocquet P, Jacquy J, Henriet M. Arzneimittelforschung; 1978 Oct 24; 28(9):1654-7. PubMed ID: 383107 [Abstract] [Full Text] [Related]
18. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results. Lanfranchi M, Magnani G, Sinforiani E, Casali R. Int J Clin Pharmacol Res; 1984 Oct 24; 4(4):307-12. PubMed ID: 6389380 [Abstract] [Full Text] [Related]